CYCC - Cyclacel Pharmaceuticals Inc
IEX Last Trade
1.04
0 0%
Share volume: 77,330
Last Updated: Fri 30 Aug 2024 09:41:42 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.04
0.00
0.00%
Fundamental analysis
25%
Profitability
25%
Dept financing
4%
Liquidity
50%
Performance
25%
Performance
5 Days
-13.76%
1 Month
-37.38%
3 Months
-47.92%
6 Months
-60.75%
1 Year
-82.10%
2 Year
-95.62%
Key data
Stock price
$1.04
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.95 - $11.34
52 WEEK CHANGE
-$0.82
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/14/2024
Company detail
CEO: Spiro Rombotis
Region: US
Website: http://www.cyclacel.com/
Employees: 15
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://www.cyclacel.com/
Employees: 15
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
cyclacel limited is a pharmaceuticals company located in 46-48 e smithfield, london, united kingdom.
Recent news